Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy

J Pediatr Hematol Oncol. 2016 Nov;38(8):653-657. doi: 10.1097/MPH.0000000000000649.

Abstract

Histiocytic sarcoma (HS), a malignant proliferation of mature tissue histiocytes presenting with single or multifocal extranodal tumors, is rarely seen in children. Primary orbital HS has never been reported in a child. Disseminated disease to the bone marrow typically has an aggressive course and poor prognosis. There is no consensus currently on the optimal therapeutic approach for HS. We present the case of a 2-year-old girl with orbital HS with likely bone marrow involvement treated successfully with multiagent chemotherapy, now in complete remission and disease free 3.5 years from end of therapy.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child, Preschool
  • Female
  • Histiocytic Sarcoma / diagnosis
  • Histiocytic Sarcoma / drug therapy*
  • Histiocytic Sarcoma / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Orbital Neoplasms / diagnosis
  • Orbital Neoplasms / drug therapy*
  • Orbital Neoplasms / pathology
  • Treatment Outcome